Triple therapy in COPD is becoming increasingly important with the cumulative documentation of its ability to reduce the risk of AECOPD. However, it must be established which patients benefit most from it compared to other treatments.
Calzetta, L., Matera, M.g., Rogliani, P., Cazzola, M. (2020). The role of triple therapy in the management of COPD. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 13(8), 865-874 [10.1080/17512433.2020.1787830].
The role of triple therapy in the management of COPD
Rogliani, Paola;Cazzola, Mario
2020-08-01
Abstract
Triple therapy in COPD is becoming increasingly important with the cumulative documentation of its ability to reduce the risk of AECOPD. However, it must be established which patients benefit most from it compared to other treatments.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
